SAN DIEGO, CA, Rejuvenate Bio, a biotechnology company developing gene therapies for age-related and chronic diseases, announced the closing of a $6 million financing round led by VCapital.
Continue Reading
Sign up for FREE to read the full article and access 131K+ alternative investment headlines.